Breast Cancer Clinical Trials in New York

Showing 101-120 of 422 trials

Study of 3-Day Partial Breast Radiation Therapy in Women With Breast Cancer

NCT04084730

The purpose of this study is to determine if the dose of radiation therapy that is effective in producing a treatment response, delivered over a shorter treatment period, is a safe approach that causes few or mild side effects in women with newly diagnosed breast cancer or DCIS who have had a lumpectomy procedure.

Invasive Ductal Breast CarcinomaInvasive Ductal Carcinoma, BreastDCIS+3 more

Memorial Sloan Kettering Cancer Center280 participantsStarted Aug 2019

Norwalk, Connecticut, United States • Miami, Florida, United States • Basking Ridge, New Jersey, United States +6 more locations

TERMINATEDPHASE1/PHASE2< 1 mile

A First-in-human Study Using BDC-1001 as a Single Agent and in Combination With Nivolumab in Advanced HER2-Expressing Solid Tumors

NCT04278144

A first-in-human study using BDC-1001 as a single agent and in combination with nivolumab in HER2 expressing advanced malignancies

HER2-positive Solid TumorsHER2-positive Breast CancerHER2-positive Colorectal Cancer+2 more

Bolt Biotherapeutics, Inc.175 participantsStarted Feb 2020

Palo Alto, California, United States • Washington D.C., District of Columbia, United States • Chicago, Illinois, United States +18 more locations

Study of 3-Day Partial Breast Radiation Therapy in Women With Breast Cancer

A First-in-human Study Using BDC-1001 as a Single Agent and in Combination With Nivolumab in Advanced HER2-Expressing Solid Tumors

Breast Cancer Trials in Other Cities

Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer

A Study of Ad-RTS-hIL-12 With Veledimex in Subjects With Breast Cancer

Dose-Response of Aerobic Training in Women at High-Risk for Development of Breast Cancer

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

Comparison of the Breast Tumor Microenvironment

Paclitaxel and Trastuzumab With or Without Lapatinib in Treating Patients With Stage II or Stage III Breast Cancer That Can Be Removed by Surgery

A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors

Veliparib With or Without Carboplatin in Treating Patients With Stage III or IV Breast Cancer

Evaluation of Talazoparib, a PARP Inhibitor, in Patients With Somatic BRCA Mutant Metastatic Breast Cancer: Genotyping Based Clinical Trial

Clinical Significance of Germline BRCA Mutations

A Study of Vericiguat in People With Breast Cancer and Cancer Therapy-Related Cardiac Dysfunction

QuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 in HER2-low Metastatic Breast Cancer

First-in-Human Study of OKI-219 in Advanced Solid Tumors and Advanced Breast Cancer

[177Lu]Lu-NeoB in Combination With Ribociclib and Fulvestrant in Participants With ER+, HER2- and GRPR+ Advanced Breast Cancer

Tucatinib, Trastuzumab, and Capecitabine for the Treatment of HER2+ LMD

Prolonged Overnight Fasting and/or Exercise on Fatigue and Other Patient Reported Outcomes in Women With Hormone Receptor Positive Advanced Breast Cancer

A Study of Trastuzumab Emtansine in Combination With Atezolizumab or Placebo as a Treatment for Participants With Human Epidermal Growth Factor 2 (HER2)-Positive and Programmed Death-ligand 1 (PD-L1)-Positive Locally Advanced (LABC) or Metastatic Breast Cancer (MBC)

A Study of ADRX-0706 in Select Advanced Solid Tumors

Other Conditions in New York